2022 annual financial data
Taysha Gene Therapies 2022 Operating margin
Taysha Gene Therapies 2022 operating margin with verified reported values.
Direct answer
Operating margin was -5,037.05%.
Operating income was -126,027,000 USD and net income was -166,014,000 USD.
Operating cash flow was -88,390,000 USD.
Get free Taysha Gene Therapies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,502,000 USD
- Operating income
- -126,027,000 USD
- Net income
- -166,014,000 USD
- Operating cash flow
- -88,390,000 USD